INVO Fertility, Inc. (IVF) stock
IVFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$2.60−0.08 (-3.17%)
Close on Nov 13, 2026Market cap $6.52MP/E –Yield –
Earnings
INVO Fertility's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Nov 16, 2026
Q3 FY2026 · estimated, before the open
Revenue, Q2 FY2026
$2.18M
+16.7% on a year earlier
EPS, Q2 FY2026
$0.35
-$13.30 a year earlier
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of INVO Fertility's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q3 FY2026ended Sep 30, 2026 | Nov 16, 2026Expected | – | – | – | – |
| Q2 FY2026ended Jun 30, 2026 | Aug 17, 2026before the open | $2.18M | +16.7% | $0.35 | Release |
| Q1 FY2026ended Mar 31, 2026 | Jun 2, 2026before the open | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 17, 2025before the open | $1.76M | – | -$0.77 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 15, 2025during market hours | $1.86M | – | -$13.30 | Release |
| Q4 FY2024ended Dec 31, 2024 | Apr 30, 2025before the open | $1.69M | +22.0% | -$9.04 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 14, 2024after the close | – | – | – | Release |
| Q1 FY2024ended Mar 31, 2024 | May 15, 2024after the close | $1.58M | +352.9% | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Apr 16, 2024after the close | $1.38M | +396.8% | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 13, 2023after the close | $974.89K | +314.3% | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 14, 2023after the close | $315.90K | +116.4% | -$3.06 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 15, 2023after the close | $348.03K | +74.0% | -$0.20 | Release |
| Q4 FY2022ended Dec 31, 2022 | Apr 17, 2023after the close | $278.14K | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 14, 2022after the close | $235.32K | +7.5% | -$0.21 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 15, 2022after the close | $146.00K | – | – | Release |
| Q1 FY2022ended Mar 31, 2022 | May 17, 2022after the close | $200.00K | – | -$0.23 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 31, 2022after the close | – | – | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 16, 2021before the open | $218.87K | – | -$0.24 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 16, 2021after the close | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 18, 2021after the close | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Mar 30, 2021after the close | – | – | – | Filing |
| Q4 FY2019ended Dec 31, 2019 | Mar 30, 2020after the close | – | – | – | Filing |
| Q2 FY2019ended Jun 30, 2019 | Aug 14, 2019after the close | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
INVO Fertility has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When INVO Fertility puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases INVO Fertility filed with the SEC as exhibits to Form 8-K or 6-K
- News
- Update
- Results
- Results
- Update
- Results
- Update
- News
- News
- News
- News
- News
- News
- News
- Results
See a number that looks wrong?